NCT02733289 Standard Follow-up Program Cervix Cancer (SFP CERVIX)
| NCT ID | NCT02733289 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Groningen |
| Condition | Cervical Cancer Radiation Complications |
| Study Type | OBSERVATIONAL |
| Enrollment | 10,000 participants |
| Start Date | 2015-06 |
| Primary Completion | 2040-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 10,000 participants in total. It began in 2015-06 with a primary completion date of 2040-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Standard evaluation and follow-up data regarding complications of curative radiation treatment for cervical cancer.
Eligibility Criteria
Inclusion Criteria: * Every cervical cancer patient with curative intent for radiotherapy, treated at our department Exclusion Criteria: * Non-curative treatment * Part of the treatment is given in another hospital
Contact & Investigator
Jannet Beukema
PRINCIPAL INVESTIGATOR
Principal Investigator
Frequently Asked Questions
Who can join the NCT02733289 clinical trial?
This trial is open to female participants only, studying Cervical Cancer Radiation Complications. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT02733289 currently recruiting?
Yes, NCT02733289 is actively recruiting participants. Contact the research team at j.c.beukema@umcg.nl for enrollment information.
Where is the NCT02733289 trial being conducted?
This trial is being conducted at Groningen, Netherlands.
Who is sponsoring the NCT02733289 clinical trial?
NCT02733289 is sponsored by University Medical Center Groningen. The principal investigator is Jannet Beukema at Principal Investigator. The trial plans to enroll 10,000 participants.
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.